Table 1 Demographic and clinical characteristics
From: Long-term Follow-up of Therapeutic ERCP in 78 Patients Aged 90 Years or Older
Group A (N = 78) | Group B (N = 312) | P value | |
|---|---|---|---|
Age (years) | 91.8 ± 1.7 (90–97) | 50.3 ± 10.8 (16–64) | <0.001 |
Sex (men/women) | 31/47 | 124/188 | 1.000 |
Clinical manifestations (n (%)) | |||
Abdominal pain | 58 (74.4%) | 260 (83.3%) | 0.068 |
Abdominal distension | 17 (21.8%) | 55 (17.6%) | 0.396 |
Jaundice | 36 (46.2%) | 121 (38.8%) | 0.235 |
Fever | 34 (43.6%) | 87 (27.9%) | 0.007 |
Nausea or vomit | 40 (51.3%) | 81 (26.0%) | <0.001 |
Poor appetite | 41 (52.6%) | 57 (18.3%) | <0.001 |
Others | 1* (1.3%) | 1** (0.03%) | - |
Chronic concomitant diseases (n (%)) | |||
Heart failure | 0 (0.0%) | 0 (0.0%) | - |
Cardiac arrhythmias | 12 (15.4%) | 3 (1.0%) | <0.001 |
Hypertension | 35 (44.9%) | 46 (14.7%) | <0.001 |
Coronary heart disease | 13 (16.7%) | 16 (5.1%) | 0.001 |
Diabetes mellitus | 15 (19.2%) | 28 (9.0%) | 0.010 |
Pulmonary diseases | 6 (7.7%) | 2 (0.6%) | <0.001 |
Liver cirrhosis | 5 (6.4%) | 9 (2.9%) | 0.134 |
Renal diseases | 2 (2.6%) | 0 (0.0%) | - |
Stroke | 4 (5.1%) | 2 (0.6%) | 0.004 |
Rheumatologic diseases | 0 (0.0%) | 4 (1.3%) | - |
Primary hyperthyroidism | 1 (1.3%) | 0 (0.0%) | - |
ASA scores (n (%)) | <0.001 | ||
1 | 35 (44.9%) | 226 (72.4%) | |
2 | 34 (43.6%) | 81 (26.0%) | |
3 | 9 (11.5%) | 5 (1.6%) | |
4 | 0 (0.00%) | 0 (0.00%) |
